Arvida Group (NS) (NZSE:ARV) 5-Year EBITDA Growth Rate : 15.70% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Arvida Group (NS) 5-Year EBITDA Growth Rate?

Arvida Group (NS)'s EBITDA per Share for the six months ended in Mar. 2024 was NZ$0.11.

During the past 12 months, Arvida Group (NS)'s average EBITDA Per Share Growth Rate was 70.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -1.40% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Arvida Group (NS) was 35.70% per year. The lowest was -31.90% per year. And the median was 14.50% per year.

Competitive Comparison of Arvida Group (NS)'s 5-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Arvida Group (NS)'s 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arvida Group (NS)'s 5-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Arvida Group (NS)'s 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Arvida Group (NS)'s 5-Year EBITDA Growth Rate falls into.

Arvida Group (NS) 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Arvida Group (NS) (NZSE:ARV) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Arvida Group (NS) 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Arvida Group (NS)'s 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Arvida Group (NS) (NZSE:ARV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Arvida Group Ltd (NS) (NZSE:ARV) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Customs Street West, Aon Centre, Level 15, Auckland, NTL, NZL, 1010

Website

https://www.arvida.co.nz

Arvida Group Ltd (NS) is engaged in operating aged care facilities and retirement villages. Aged care facilities include rest homes, hospitals, and secure dementia care. Retirement living consists of the independent living facility which provides residents to continue living independently and to enjoy a retirement village lifestyle and facilities knowing that care is available if and when they should need it, and assisted living which is focused on providing residents with the support and care they require. The group provides services primarily in New Zealand.

Arvida Group (NS) (NZSE:ARV) Headlines

No Headlines